GRMH Graymark Healthcare, Inc. featured news, full reports, and detailed charts
Graymark Healthcare, Inc. (GRMH) Wrap Up:
Graymark Healthcare, Inc. acquires and operates independent retail pharmacy stores that sell prescription drugs and a small assortment of general merchandise in the United States. The company operates in two segments, Apothecary and SDC. The Apothecary segment involves in the retail sale of prescription drugs, non-prescription over-the-counter drugs and health related products, including diabetic merchandise, over the counter drugs, compounded pharmaceuticals, durable medical equipment, and assisted and group living deliveries, beauty products and cosmetics, seasonal merchandise, greeting cards, and convenience foods. As of March 15, 2008, it operated 12 retail pharmacies in Colorado, Illino...Graymark Healthcare, Inc. (GRMH:NASDAQ)
Snapshot of Graymark Healthcare, Inc. (GRMH)
|
OPEN
$2.00
|
PREVIOUS CLOSE
$1.95
|
|
|
DAY HIGH
$2.15
|
DAY LOW
$2.00
|
|
|
52 WEEK HIGH
09/18/09 - $3.85
|
52 WEEK LOW
07/10/09 - $0.95
|
|
|
MARKET CAP
60.9M
|
AVERAGE VOLUME 3 mo
5.3K
|
|
|
DILUTED EPS TTM
--
|
SHARES OUTSTANDING
29.0M
|
|
|
GRMH Does Not Pay Dividends
|
P/E TTM
NM
|
|
| K = Thousands M = Millions B = Billions | ||
GRMH Top Compensated Officers
Executives, Board Directors
Key developments for Graymark Healthcare, Inc. (GRMH)
Graymark Healthcare Inc. announced that effective September 30, 2009, the appointment of Lewis P. Zeidner as Chief Operating Officer. Joseph Harroz, Jr., formerly appointed dual roles of President and Chief Operating Officer, will continue in his role as President and a member of Board of Directors. Mr. Zeidner has served as President and Chief Executive Officer of wholly owned subsidiary, ApothecaryRx LLC, since its founding in 2006 and will continue in this role.
Graymark Healthcare Inc. reported earnings results for the second quarter ended June 30, 2009. For the quarter, net revenue increased 9% to $25.3 million, compared to $23.3 million in the second quarter of 2008. Due principally to a change in accounting estimate, net loss attributable to the company was $2.8 million, or $0.10 per diluted share compared to net income of $368,000, or $0.01 per diluted share for the second quarter of 2008. Without the change in accounting estimate, net loss attributable to the company would have been $0.2 million or $0.1 per diluted share compared to net income of $0.01 per diluted share for the second quarter of 2008.
Graymark Healthcare, Inc., Q2 2009 Earnings Call, Aug 24 2009
GRMH Competitors
| Company | Last | Change |
| CVS Caremark Corp | $31.64 USD | +0.56 |
| Lincare Holdings | $35.38 USD | +0.57 |
| Rite Aid Corp | $1.28 USD | -0.06 |
| Target Corporation | $47.46 USD | -0.44 |
| Walgreens | $38.97 USD | -0.06 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | GRMH | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.6x |
|
| Price/Book | 3.0x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 0.0x |
|
|
GRMH |
||
GRMH transactions
| Type Date |
Target |
|
Private Placement
September 15, 2009 |
-- |